The goal of this pre-pilot for the clinical trial is to develop a mobile health (mHealth) program called WINGS+++ can help women with opioid use disorder or other substance use disorders who have experienced intimate partner violence. The pre-pilot study will take place in Orange County, New York with n=7 women. .
The main questions it aims to answer are:
1. Does WINGS+++ lower non-prescription opioid and other drug use in women? 2. Does WINGS+++ help connect women to treatment for substance use, intimate partner violence, and post-traumatic stress disorder (PTSD)?
Researchers will compare WINGS+++ to standard care to see if WINGS+++ works better to lower drug use and link women to helpful services.
WINGS+++ is a 3-session program on a mobile device that:
* Screens for intimate partner violence, PTSD, and substance use * Offers brief support and referrals based on each woman's needs and preferences * Connects women to a peer navigator who helps link them to services
Participants will:
* Take part in only the WINGS+++ program for the pre-pilot * Answer survey questions about drug use, intimate partner violence, and PTSD symptoms * Provide biological samples (such as urine or hair) to check for drug use * Share information about the services they have used
Identify as a woman (cis-gender or transgender)
Aged 18 or older
Report use of non-prescribed opioids in the past 30 days
Score positive for risk of opioid use disorder or other substance use disorder on the Drug Abuse Screening Test (DAST) with a cut-off score of 6 or higher
Evidence of significant psychiatric or cognitive impairment that would limit effective participation, as confirmed during informed consent
Inability to speak and understand English sufficiently to participate in assessments or intervention sessions
Dawn A. Goddard-Eckrich
Lead sponsor
Columbia University
Sponsor institution
National Institute on Drug Abuse (NIDA)
Collaborator
City University of New York
Collaborator
University of Pennsylvania
Collaborator